MRSN - Mersana Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue10,59417,54525,17110,359
Cost of Revenue59,91546,70032,00821,353
Gross Profit-49,321-29,155-6,837-10,994
Operating Expenses
Research Development----
Selling General and Administrative16,33410,4626,9845,347
Non Recurring----
Others----
Total Operating Expenses76,24957,16238,99226,700
Operating Income or Loss-65,655-39,617-13,821-16,341
Income from Continuing Operations
Total Other Income/Expenses Net2,796910121-87
Earnings Before Interest and Taxes-65,655-39,617-13,821-16,341
Interest Expense----
Income Before Tax-64,257-38,707-13,700-16,428
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-64,257-38,707-13,700-16,428
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-64,257-38,707-13,700-16,428
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-64,257-38,707-13,700-16,428